Neutralizing mAbs targeting Notch receptors or ligands, such as delta ligand-4 (DLL4), have also been developed to block Notch signaling and were reported to reduce colorectal CSC self-renewal and tumor growth in vivo [196]. The gene discussed is DLL4; the disease is neoplasm.